CEFALY Technology

General Information

Company Name

CEFALY Technology

Founded Year

2004

Location (Offices)

Darien, United States +2

Founders / Decision Makers

Number of Employees

Industries

Medical Devices

Funding Stage

Private Equity

Social Media

CEFALY Technology - Company Profile

CEFALY Technology is a global medical technology company that aims to combat the persistent issue of migraine through innovative therapeutic solutions. The company's flagship product, CEFALY DUAL, is an FDA Cleared and CE Marked device designed to offer a safe and effective, drug-free treatment for individuals suffering from migraines. Since its inception in 2004, the company has been dedicated to refining and enhancing the CEFALY DUAL device, which targets the trigeminal nerve, a key factor in migraine sensation. This proprietary technology works to modify pain sensation in the trigeminal nerve through its ophthalmic branch, located beneath the skin of the forehead.

CEFALY Technology has seen support from DW Healthcare Partners, who participated in a recent Private Equity Round investment in the company as of August 8, 2019. With its focus on leveraging advanced medical innovations to address the complexities of migraine, CEFALY Technology remains an intriguing player in the healthcare technology sector.

Taxonomy: migraine treatment, FDA cleared, CE marked, drug-free treatment, trigeminal nerve, pain sensation modification, proprietary device, cephalic, ophthalmic branch, headache management, chronic pain management